Sleep, immunity and inflammation in gastrointestinal disorders

World Journal of Gastroenterology

Volumn 19, Issue 48, 2013, Pages 9231-9239

  Ali, Tauseef ^a   Choe, James ^b   Awab, Ahmed ^c   Wagener, Theodore L ^b   Orr, William C ^b,d  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c Pulmonary Diseases Critical Care and Sleep Medicine Section   (United States)

^d LYNN HEALTH SCIENCE INSTITUTE   (United States)

Author keywords

Circadian rhythm; Colon cancer; Gastroesophageal reflux disease; Immune function; Immunity; Inflammatory bowel disease; Irritable bowel syndrome; Liver disorders; Sleep

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MELATONIN; NITRIC OXIDE; PROTEIN BMAL1; SEROTONIN; SEROTONIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

CIRCADIAN RHYTHM; COLON CANCER; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HUMAN; HYPERALGESIA; IMMUNITY; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; MORTALITY; NONHUMAN; PEPTIC ULCER; PERISTALSIS; QUALITY OF LIFE; REM SLEEP; REVIEW; SLEEP; SLEEP DISORDER; SUPRACHIASMATIC NUCLEUS; UPPER RESPIRATORY TRACT INFECTION;

CIRCADIAN RHYTHM; COLON CANCER; GASTRO-ESOPHAGEAL REFLUX DISEASE; IMMUNE FUNCTION; IMMUNITY; INFLAMMATORY BOWEL DISEASE; IRRITABLE BOWEL SYNDROME; LIVER DISORDERS; SLEEP;

ANIMALS; GASTROINTESTINAL DISEASES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATION MEDIATORS; PROGNOSIS; RISK FACTORS; SLEEP; SLEEP DISORDERS;

EID: 84891457145     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i48.9231     Document Type: Review

References (103)

1. Reid KJ, Martinovich Z, Finkel S, Statsinger J, Golden R, Harter K, Zee PC. Sleep: a marker of physical and mental health in the elderly. Am J Geriatr Psychiatry 2006; 14: 860-866 [PMID: 17001025 DOI: 10.1097/01.JGP.0000206164.56404.ba]
2. Zee PC, Turek FW. Sleep and health: Everywhere and in both directions. Arch Intern Med 2006; 166: 1686-1688 [PMID: 16983044 DOI: 10.1001/archinte.166.16.1686]
3. Luyster FS, Strollo PJ, Zee PC, Walsh JK. Sleep: a health imperative. Sleep 2012; 35: 727-734 [PMID: 22654183 DOI:10.5665/sleep.1846]
4. Johnson DA. Gastroesophageal reflux disease and sleep disorders: a wake-up call for physicians and their patients. Rev Gastroenterol Disord 2005; 5 Suppl 2: S3-11 [PMID: 16369222]
5. Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R. An epidemiological study of insomnia among the Japanese general population. Sleep 2000; 23: 41-47 [PMID: 10678464]
6. Fetveit A, Straand J, Bjorvatn B. Sleep disturbances in an arctic population: the Tromsø Study. BMC Health Serv Res 2008; 8: 117 [PMID: 18510767 DOI: 10.1186/1472-6963-8-117]
7. Maneerattanaporn M, Chey WD. Sleep disorders and gastrointestinal symptoms: chicken, egg or vicious cycle? Neurogastroenterol Motil 2009; 21: 97-99 [PMID: 19215586 DOI:10.1111/j.1365-2982.2008.01254.x]
8. Ohayon MM, Paiva T. Global sleep dissatisfaction for the assessment of insomnia severity in the general population of Portugal. Sleep Med 2005; 6: 435-441 [PMID: 16085459 DOI:10.1016/j.sleep.2005.03.006]
9. Orr WC. Sleep and gastrointestinal disease: a new horizon in sleep medicine. Sleep Med 2009; 10: 595-596 [PMID: 19403334 DOI: 10.1016/j.sleep.2009.03.001]
10. Balkin TJ, Rupp T, Picchioni D, Wesensten NJ. Sleep loss and sleepiness: current issues. Chest 2008; 134: 653-660 [PMID: 18779203 DOI: 10.1378/chest.08-1064]
11. Palma BD, Tiba PA, Machado RB, Tufik S, Suchecki D. [Immune outcomes of sleep disorders: the hypothalamic-pituitary-adrenal axis as a modulatory factor]. Rev Bras Psiquiatr 2007; 29 Suppl 1: S33-S38 [PMID: 17546346]
12. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001; 107: 165-170 [PMID: 11150007 DOI:10.1067/mai.2001.112270]
13. Stickgold R. Sleep-dependent memory consolidation. Nature 2005; 437: 1272-1278 [PMID: 16251952 DOI: 10.1038/nature04286]
14. Balachandran D. Sleep and the immune system: implications for health and mortality. Sleep and Safety 2011; 52-59 [DOI: 10.2174/9781608052714111010]
15. Czeisler CA, Gooley JJ. Sleep and circadian rhythms in humans. Cold Spring Harb Symp Quant Biol 2007; 72: 579-597 [PMID: 18419318 DOI: 10.1101/sqb.2007.72.064]
16. Bechtold DA, Gibbs JE, Loudon AS. Circadian dysfunction in disease. Trends Pharmacol Sci 2010; 31: 191-198 [PMID: 20171747 DOI: 10.1016/j.tips.2010.01.002]
17. Borbély AA. Refining sleep homeostasis in the two-process model. J Sleep Res 2009; 18: 1-2 [PMID: 19250170 DOI: 10.1111 /j. 1365-2869.2009.00750.x]
18. Gamaldo CE, Shaikh AK, McArthur JC. The sleep-immunity relationship. Neurol Clin 2012; 30: 1313-1343 [PMID: 23099140]
19. Panda S, Hogenesch JB, Kay SA. Circadian rhythms from flies to human. Nature 2002; 417: 329-335 [PMID: 12015613 DOI: 10.1038/417329a]
20. Delezie J, Challet E. Interactions between metabolism and circadian clocks: reciprocal disturbances. Ann N Y Acad Sci 2011; 1243: 30-46 [PMID: 22211891 DOI: 10.1111/ j.1749-6632.2011.06246.x]
21. Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science 2010; 330: 1349-1354 [PMID: 21127246 DOI: 10.1126/science.1195027]
22. Bollinger T, Bollinger A, Oster H, Solbach W. Sleep, immunity, and circadian clocks: a mechanistic model. Gerontology 2010; 56: 574-580 [PMID: 20130392 DOI: 10.1159/000281827]
23. Jones CR, Campbell SS, Zone SE, Cooper F, DeSano A, Murphy PJ, Jones B, Czajkowski L, Ptácek LJ. Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans. Nat Med 1999; 5: 1062-1065 [PMID: 10470086 DOI: 10.1038/12502]
24. Kyriacou CP, Hastings MH. Circadian clocks: genes, sleep, and cognition. Trends Cogn Sci 2010; 14: 259-267 [PMID: 20418150 DOI: 10.1016/j.tics.2010.03.007]
25. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptácek LJ, Fu YH. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001; 291: 1040-1043 [PMID: 11232563]
26. Hoogerwerf WA. Role of biological rhythms in gastrointestinal health and disease. Rev Endocr Metab Disord 2009; 10: 293-300 [PMID: 19798581 DOI: 10.1007/s11154-009-9119-3]
27. Konturek PC, Brzozowski T, Konturek SJ. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol 2011; 62: 139-150 [PMID: 21673361]
28. Haus E, Smolensky MH. Biologic rhythms in the immune system. Chronobiol Int 1999; 16: 581-622 [PMID: 10513884]
29. Lange T, Dimitrov S, Born J. Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci 2010; 1193: 48-59 [PMID: 20398008 DOI: 10.1111/ j.1749-6632.2009.05300.x]
30. Ranjbaran Z, Keefer L, Stepanski E, Farhadi A, Keshavarzian A. The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res 2007; 56: 51-57 [PMID: 17431741 DOI: 10.1007/s00011-006-6067-1]
31. Majde JA, Krueger JM. Links between the innate immune system and sleep. J Allergy Clin Immunol 2005; 116: 1188-1198 [PMID: 16337444 DOI: 10.1016/j.jaci.2005.08.005]
32. Imeri L, Opp MR. How (and why) the immune system makes us sleep. Nat Rev Neurosci 2009; 10: 199-210 [PMID: 19209176 DOI: 10.1038/nrn2576]
33. Späth-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL, Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 1998; 83: 1573-1579 [PMID: 9589658]
34. Opp MR, Krueger JM. Anti-interleukin-1 beta reduces sleep and sleep rebound after sleep deprivation in rats. Am J Physiol 1994; 266: R688-R695 [PMID: 8160860]
35. Franklin CM. Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis. Semin Arthritis Rheum 1999; 29: 172-181 [PMID: 10622681]
36. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-1316 [PMID: 9141509]
37. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 1999; 84: 2603-2607 [PMID: 10443646]
38. Norman SE, Chediak AD, Kiel M, Cohn MA. Sleep disturbances in HIV-infected homosexual men. AIDS 1990; 4: 775-781 [PMID: 2261133]
39. Opp MR. Cytokines and sleep. Sleep Med Rev 2005; 9: 355-364 [PMID: 16102986]
40. Gemma C, Imeri L, Opp MR. Serotonergic activation stimulates the pituitary-adrenal axis and alters interleukin-1 mRNA expression in rat brain. Psychoneuroendocrinology 2003; 28: 875-884 [PMID: 12892655]
41. Toth LA. Microbial modulation of sleep. In: Handbook of behav state cntrl: cellu and molec mechs. Boca Raton: CRC Press, 1999: 641-657
42. Toth LA, Tolley EA, Krueger JM. Sleep as a prognostic indicator during infectious disease in rabbits. Proc Soc Exp Biol Med 1993; 203: 179-192 [PMID: 8502660]
43. Everson CA. Sustained sleep deprivation impairs host defense. Am J Physiol 1993; 265: R1148-R1154 [PMID: 8238617]
44. Spiegel K, Sheridan JF, Van Cauter E. Effect of sleep deprivation on response to immunization. JAMA 2002; 288: 1471-1472 [PMID: 12243633]
45. Cohen FL, Ferrans CE, Vizgirda V, Kunkle V, Cloninger L. Sleep in men and women infected with human immunodeficiency virus. Holist Nurs Pract 1996; 10: 33-43 [PMID: 8717996]
46. Perras B, Borna J. Sleep associated endocrine and immune changes in the elderly. Adv Cell Aging Gerontol 2005; 17: 113-154 [DOI: 10.1016/S1566-3124(04)17005-3]
47. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190-200 [PMID: 15654800 DOI:10.1111/j.1572-0241.2005.41217.x]
48. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-717 [PMID: 15831922 DOI: 10.1136/ gut.2004.051821]
49. Farup C, Kleinman L, Sloan S, Ganoczy D, Chee E, Lee C, Revicki D. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001; 161: 45-52 [PMID: 11146697 DOI: 10.1001/archinte.161.1.45]
50. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 2003; 98: 1487-1493 [PMID: 12873567 DOI: 10.1111/j.1572-0241.2003.07531.x]
51. Orr WC. Review article: sleep-related gastro-oesophageal reflux as a distinct clinical entity. Aliment Pharmacol Ther 2010; 31: 47-56 [PMID: 19691671 DOI: 10.1111/j.1365-2036.2009.04124.x]
52. Dickman R, Green C, Fass SS, Quan SF, Dekel R, Risner-Adler S, Fass R. Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. J Clin Sleep Med 2007; 3: 505-513 [PMID: 17803014]
53. Onen SH, Alloui A, Gross A, Eschallier A, Dubray C. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 2001; 10: 35-42 [PMID: 11285053 DOI:10.1046/j.1365-2869.2001.00240.x]
54. Schey R, Dickman R, Parthasarathy S, Quan SF, Wendel C, Merchant J, Powers J, Han B, van Handel D, Fass R. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 2007; 133: 1787-1795 [PMID: 18054551 DOI: 10.1053/j.gastro.2007.09.039]
55. Huang KW, Luo JC, Leu HB, Lin HC, Lee FY, Chan WL, Lin SJ, Chen JW, Chang FY. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study. Aliment Pharmacol Ther 2012; 35: 796-802 [PMID: 22348540 DOI: 10.1111/ j.365-2036.12.05028.x]
56. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5: 1424-1429 [PMID: 17904915 DOI: 10.1016/ j.cgh.2007.07.012]
57. Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol 2007; 22: 1748-1753 [PMID: 17914945 DOI: 10.1111/j.1440-1746.2006.04820.x]
58. Preuss F, Tang Y, Laposky AD, Arble D, Keshavarzian A, Turek FW. Adverse effects of chronic circadian desynchronization in animals in a "challenging" environment. Am J Physiol Regul Integr Comp Physiol 2008; 295: R2034-R2040 [PMID: 18843092 DOI: 10.1152/ajpregu.00118.2008]
59. Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 1990; 31: 1037-1040 [PMID: 2210450 DOI: 10.1136/gut.31.9.1037]
60. Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol 2011; 7: 29-36 [PMID: 21162647 DOI: 10.1586/eci.10.83]
61. Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol 2013; 11: 965-971 [PMID: 23376797 DOI:10.1016/j.cgh.2013.01.021]
62. Tang Y, Preuss F, Turek FW, Jakate S, Keshavarzian A. Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis. Sleep Med 2009; 10: 597-603 [PMID: 19403332 DOI: 10.1016/j.sleep.2008.12.009]
63. Ali T, Madhoun MF, Orr WC, Rubin DT. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19: 2440-2443 [PMID: 23945186 DOI: 10.1097/ MIB.0b013e3182a0ea54]
64. Ali T, Madhoun MF, Crosby A, Orr WC, Rubin DT. 43 Poor Sleep Quality Predicts Disease Relapse in Patients With Inflammatory Bowel Disease. Gastroenterology 2013; 144 Suppl 1: S-12 [DOI: 10.1016/S0016-5085(13)60039-6]
65. De Filippis D, Iuvone T, Esposito G, Steardo L, Arnold GH, Paul AP, De Man Joris G, De Winter Benedicte Y. Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. J Pineal Res 2008; 44: 45-51 [PMID: 18078447 DOI: 10.1111/ j.1600-079X.2007.00526.x]
66. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200 [PMID: 16217132]
67. Johe PD, Østerud B. The in vivo effect of melatonin on cellular activation processes in human blood during strenuous physical exercise. J Pineal Res 2005; 39: 324-330 [PMID: 16150115 DOI: 10.1111/j.1600-079X.2005.00254.x]
68. Terry PD, Villinger F, Bubenik GA, Sitaraman SV. Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research. Inflamm Bowel Dis 2009; 15: 134-140 [PMID: 18626968 DOI: 10.1002/ibd.20527]
69. Ishiguro Y. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol 1999; 34: 66-74 [PMID: 10204613 DOI: 10.1007/ s005350050218]
70. Olsen T, Goll R, Cui G, Husebekk A, Vonen B, Birketvedt GS, Florholmen J. Tissue levels of tumor necrosis factoralpha correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol 2007; 42: 1312-1320 [PMID: 17852866 DOI: 10.1080/00365520701409035]
71. Umehara Y, Kudo M, Nakaoka R, Kawasaki T, Shiomi M. Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. Hepatogastroenterology 2006; 53: 879-882 [PMID: 17153445]
72. Sands BE, Kaplan GG. The role of TNFalpha in ulcerative colitis. J Clin Pharmacol 2007; 47: 930-941 [PMID: 17567930 DOI: 10.1177/0091270007301623]
73. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-934 [PMID: 1889716]
74. Kim HI, Jung SA, Choi JY, Kim SE, Jung HK, Shim KN, Yoo K. Impact of shiftwork on irritable bowel syndrome and functional dyspepsia. J Korean Med Sci 2013; 28: 431-437 [PMID: 23487413 DOI: 10.3346/jkms.2013.28.3.431]
75. Chen CL, Liu TT, Yi CH, Orr WC. Evidence for altered anorectal function in irritable bowel syndrome patients with sleep disturbance. Digestion 2011; 84: 247-251 [PMID: 21952561 DOI: 10.1159/000330847]
76. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
77. Berger AM, Grem JL, Visovsky C, Marunda HA, Yurkovich JM. Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer. Oncol Nurs Forum 2010; 37: E359-E369 [PMID: 21059569 DOI: 10.1188/10.onf. e359-e369]
78. Cera SM, Wexner SD. Minimally invasive treatment of colon cancer. Cancer J 2005; 11: 26-35 [PMID: 15831221 DOI: 10.1097/00130404-200501000-00005]
79. Shelton BK. Introduction to colorectal cancer. Semin Oncol Nurs 2002; 18: 2-12 [PMID: 12053860 DOI: 10.1053/sonu.2002.33074]
80. Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res 1999; 8: 181-195 [PMID: 10472150 DOI:10.1023/A:1008821826499]
81. Osoba D, Hsu MA, Copley-Merriman C, Coombs J, Johnson FR, Hauber B, Manjunath R, Pyles A. Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Qual Life Res 2006; 15: 273-283 [PMID: 16468082 DOI: 10.1007/s11136-005-0580-5]
82. Guess J, Burch JB, Ogoussan K, Armstead CA, Zhang H, Wagner S, Hebert JR, Wood P, Youngstedt SD, Hofseth LJ, Singh UP, Xie D, Hrushesky WJ. Circadian disruption, Per3, and human cytokine secretion. Integr Cancer Ther 2009; 8: 329-336 [PMID: 19926609 DOI: 10.1177/1534735409352029]
83. Filipski E, King VM, Li X, Granda TG, Mormont MC, Claustrat B, Hastings MH, Lévi F. Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol (Paris) 2003; 51: 216-219 [PMID: 12852994 DOI: 10.1016/ S0369-8114(03)00034-8]
84. Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant lightinduced nocturnal melatonin suppression. Breast Cancer Res Treat 2003; 79: 313-320 [PMID: 12846415 DOI: 10.1023/ A:1024030518065]
85. Thompson CL, Larkin EK, Patel S, Berger NA, Redline S, Li L. Short duration of sleep increases risk of colorectal adenoma. Cancer 2011; 117: 841-847 [PMID: 20936662 DOI: 10.1002/ cncr.25507]
86. Reed VA. Shift work, light at night, and the risk of breast cancer. AAOHN J 2011; 59: 37-45; quiz 46 [PMID: 21175107 DOI: 10.3928/08910162-20101216-01]
87. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003; 95: 825-828 [PMID: 12783938 DOI: 10.1093/ jnci/95.11.825]
88. Wiseman M. The second World Cancer Research Fund/ American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67: 253-256 [PMID: 18452640 DOI: 10.1017/s002966510800712x]
89. Basterfield L, Mathers JC. Intestinal tumours, colonic butyrate and sleep in exercised Min mice. Br J Nutr 2010; 104: 355-363 [PMID: 20334709 DOI: 10.1017/s0007114510000528]
90. Vijayalaxmi CR, Reiter RJ, Herman TS. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002; 20: 2575-2601 [PMID: 12011138 DOI: 10.1200/JCO.2002.11.004]
91. Córdoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998; 27: 339-345 [PMID: 9462628]
92. Bismuth M, Funakoshi N, Cadranel JF, Blanc P. Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol 2011; 23: 8-22 [PMID: 21099434 DOI: 10.1097/MEG.0b013e3283417567]
93. Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 2006; 44: 91-98 [PMID: 16800007 DOI: 10.1002/hep.21230]
94. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113-119 [PMID: 7806143]
95. Carlson MD, Hilsabeck RC, Barakat F, Perry W. Role of Sleep Disturbance in Chronic Hepatitis C Infection. Curr Hepat Rep 2010; 9: 25-29 [PMID: 20208985 DOI: 10.1007/ s11901-010-0030-x]
96. Raison CL, Rye DB, Woolwine BJ, Vogt GJ, Bautista BM, Spivey JR, Miller AH. Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry 2010; 68: 942-949 [PMID: 20537611 DOI: 10.1016/j.biopsych.2010.04.019]
97. Summa KC, Voigt RM, Forsyth CB, Shaikh M, Cavanaugh K, Tang Y, Vitaterna MH, Song S, Turek FW, Keshavarzian A. Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation. PLoS One 2013; 8: e67102 [PMID: 23825629 DOI: 10.1371/journal.pone.0067102]
98. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809 [PMID: 19855405 DOI: 10.1038/nri2653]
99. Rybarczyk B, Stepanski E, Fogg L, Lopez M, Barry P, Davis A. A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J Consult Clin Psychol 2005; 73: 1164-1174 [PMID: 16392989 DOI: 10.1037/0022-006 X.73.6.1164]
100. Jungquist CR, O'Brien C, Matteson-Rusby S, Smith MT, Pigeon WR, Xia Y, Lu N, Perlis ML. The efficacy of cognitivebehavioral therapy for insomnia in patients with chronic pain. Sleep Med 2010; 11: 302-309 [PMID: 20133188 DOI:10.1016/j.sleep.2009.05.018]
101. Jungquist CR, Tra Y, Smith MT, Pigeon WR, Matteson-Rusby S, Xia Y, Perlis ML. The durability of cognitive behavioral therapy for insomnia in patients with chronic pain. Sleep Disord 2012; 2012: 679648 [PMID: 23470897 DOI:10.1155/2012/679648]
102. Edinger JD, Wohlgemuth WK, Krystal AD, Rice JR. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med 2005; 165: 2527-2535 [PMID: 16314551 DOI: 10.1001/archinte.165.21.2527]
103. Currie SR, Wilson KG, Pontefract AJ, deLaplante L. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 2000; 68: 407-416 [PMID: 10883557]